About

Dr. Karen Anderson is a tumor biologist specializing in how the immune system can be harnessed to detect and modify cancer development. Her research focuses on identifying biomarkers, such as specific antibodies produced in response to cancer, to enable early detection of cancers including breast, ovarian, pancreatic, and HPV-related cancers. She employs molecular techniques like in vitro protein arrays, next-generation sequencing, and high-throughput functional genomics to study early alterations in cancer and to identify novel targets for treatment and vaccine development. Her laboratory is dedicated to understanding immune responses for cancer detection and immunotherapy. This includes identifying target antigens for vaccine development and elucidating mechanisms of immune regulation that limit effective immunotherapy. The team uses proteomic tools for immunoprofiling in cancer and infectious diseases, aiming to improve early detection and monitoring strategies. Dr. Anderson's work contributes to advancing cancer immunotherapy, early detection biomarkers, and understanding immune dysfunction in cancer, with a particular emphasis on HPV-associated cancers and breast cancer.

Research topics

• Medicine
• Biology
• Internal medicine
• Oncology
• Immunology

Frequent coauthors

• Joshua LaBaer

  Arizona State University

  86 shared

• Robert H. Vonderheide

  72 shared

• Joachim L. Schultze

  University of Bonn

  72 shared

• Lee M. Nadler

  69 shared

• Britta Maecker

  65 shared

• Michael S. von Bergwelt‐Baildon

  63 shared

• Ibrahim G Tsolakian

  University of Toledo

  60 shared

• Lori Koslosky

  Fox Chase Cancer Center

  53 shared

Education

• Ph.D., Microbiology and Immunology

  Duke University

• M.D., Medical Scientist Training Program

  Duke University School of Medicine

• B.A., Chemistry

  University of Virginia

Similar researchers at Arizona State University

• Greg Asnerh-157
• Philip Christensenh-130
• Jianguo Wuh-119
• Carolyn Comptonh-118
• Osvaldo Salah-114